Accuray Incorporated (ARAY) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $0.38 (+28.45%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| May 2, 2024 | Maria Thibault | BTIG | $6.00 | +1478.9% |
Top Analysts Covering ARAY
ARAY vs Sector & Market
| Metric | ARAY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +426.3% | +1710.4% | +16.4% |
| P/E Ratio | -1.46 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $442M | $443M | $444M | 1 |
| 2027-06-30 | $462M | $463M | $465M | 1 |
| 2028-06-30 | $483M | $483M | $483M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.32 | $-0.32 | $-0.32 | 1 |
| 2027-06-30 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2028-06-30 | $0.12 | $0.12 | $0.12 | 1 |
Frequently Asked Questions
What is the analyst consensus for ARAY?
The consensus among 2 analysts covering Accuray Incorporated (ARAY) is Buy with an average price target of $2.00.
What is the highest price target for ARAY?
The highest price target for ARAY is $6.00, set by Maria Thibault at BTIG on 2024-05-02.
What is the lowest price target for ARAY?
The lowest price target for ARAY is $6.00, set by Maria Thibault at BTIG on 2024-05-02.
How many analysts cover ARAY?
2 analysts have issued ratings for Accuray Incorporated in the past 12 months.
Is ARAY a buy or sell right now?
Based on 2 analyst ratings, ARAY has a consensus rating of Buy (2.50/5) with a +426.3% upside to the consensus target of $2.00.
What are the earnings estimates for ARAY?
Analysts estimate ARAY will report EPS of $-0.32 for the period ending 2026-06-30, with revenue estimated at $443M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.